Discovery and structure–activity relationship of plastoquinone analogs as anticancer agents against chronic myelogenous leukemia cells
- 11 October 2019
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 352 (12), e1900170
- https://doi.org/10.1002/ardp.201900170
Abstract
Two series of amino‐1,4‐benzoquinones (AQ1–18) based on the structural analogs of plastoquinones were synthesized and the structure–activity relationship against chronic myelogenous leukemia activity was examined. All of the synthesized compounds were tested for their cytotoxic effects on different leukemic cell lines. Of interest, AQ15 exhibited a better selectivity than the reference drug imatinib on cancer cells. Owing to this, AQ15 was selected for a further apoptosis/necrosis evaluation where AQ15‐treated K562 cells demonstrated similar apoptotic effects like imatinib‐treated cells at their IC50 values. The inhibitory effects of AQ15 and the other three compounds with various activities against eight tyrosine kinases, including ABL1, were investigated. AQ15 showed weak activity against ABL1, and a correlation was observed between the anti‐K562 and anti‐ABL1 activities. The binding mode of AQ15 into the ATP binding pocket of ABL1 kinase was predicted in silico, showing the formation of some key interactions. In addition, AQ15 was shown to suppress the downstream signaling of BCR‐ABL in K562 cells. Finally, AQ15 obviously cleaved DNA in the presence of an iron(II) complex system, indicating that this can be the major mechanism of its antiproliferative action, whereas the mild inhibition of ABL kinase is just in‐part mechanism of its overall outstanding cellular activity.Keywords
This publication has 59 references indexed in Scilit:
- High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitorsAntiviral Research, 2011
- Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitorsBioorganic & Medicinal Chemistry, 2010
- ‘On water’ assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agentsEuropean Journal of Medicinal Chemistry, 2010
- Structure-Activity Studies on Therapeutic Potential of Thymoquinone Analogs in Pancreatic CancerPharmaceutical Research, 2010
- Structure validation in chemical crystallographyActa crystallographica. Section D, Structural biology, 2009
- Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studiesBiochemistry (Moscow), 2008
- The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cellsOncogene, 2007
- Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activityBioorganic & Medicinal Chemistry, 2007
- DNA Binding and Cleavage of a Novel Antitumor Antibiotic Dynemicin A: Detection of Binding and Cleavage Sites by Exonuclease III Digestion and Alkali-Induced Cutting ReactionsBiochemical and Biophysical Research Communications, 1993
- Modification of deoxyribonucleic acid with reductively activated mitomycin C. Structures of modified nucleotides.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983